Aptose Biosciences
APTO
#10034
Rank
A$21.37 M
Marketcap
$0.35
Share price
3.33%
Change (1 day)
-89.67%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2024 (TTM): -A$53.82 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$84.53 Million a decrease over its 2022 earnings that were of -A$68.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$53.82 Million-36.33%
2023 -A$84.53 Million22.9%
2022 -A$68.78 Million-34.91%
2021 -A$0.11 Billion17.36%
2020 -A$90.04 Million107.65%
2019 -A$43.36 Million-7.73%
2018 -A$47 Million160.68%
2017 -A$18.03 Million-20.27%
2016 -A$22.61 Million28.71%
2015 -A$17.57 Million
2013 -A$9.96 Million
2010 -A$8.49 Million-8.31%
2009 -A$9.25 Million
2006 -A$17.15 Million-156.93%
2005 A$30.12 M-185.16%
2004 -A$35.37 Million458.58%
2003 -A$6.34 Million-63.66%
2002 -A$17.43 Million-8.04%
2001 -A$18.95 Million16.73%
2000 -A$16.24 Million294.99%
1999 -A$4.11 Million-6.51%
1998 -A$4.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$54.93 Million-6.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$69.56 Million 19.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.11 Billion 73.44%๐Ÿ‡บ๐Ÿ‡ธ USA